Next-generation sequencing-based multiplex cancer screening panel for simultaneous detection of multiple cancer types. This advanced molecular diagnostic test enables comprehensive cancer risk stratification from single blood samples. The product is in development as part of the company's precision ...
Manufactured by
China
BioChain (Beijing) Science & Technology Inc. is a pioneer in cancer early diagnosis and screening in China. The company specializes in developing NGS and PCR-based cancer gene methylation detection products, focusing on early cancer diagnosis reagent kits and large-scale laboratory screening platforms.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Burning Rock Dx Co. Ltd.
China · 6 relevant products
YouSeq
United Kingdom · 2 relevant products
Genes 2Me Private Ltd
India · 6 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 1 relevant product
Medicover Genetics Ltd
Cyprus · 2 relevant products
Rayto Life and Analytical Sciences Co., Ltd.
China · 1 relevant product
Guangzhou LBP Medicine Science & Technology Co.,Ltd.
China · 1 relevant product
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 1 relevant product
Daan Gene Co., Ltd.
China · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 3 relevant products
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 99 closest product alternatives
Burning Rock Dx Co. Ltd. · China
Next-generation sequencing panel for comprehensive cancer genomic profiling. Identifies mutations, copy number variations, and other genetic alterations to guide personalized treatment strategies.
YouSeq · United Kingdom
A multiplex molecular panel utilizing qPCR and NGS technology for detection of breast cancer-associated genetic markers and mutations. Supports diagnostic confirmation and prognostic assessment for breast cancer management.
Genes 2Me Private Ltd · India
Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cancer screening and early detection. Part of the comprehensive oncology testing portfolio covering multiple cancer types.
Medicover Genetics Ltd · Cyprus
Genetic testing for cancer predisposition and somatic cancer variants to identify individuals at risk or with diagnosed malignancies. Includes comprehensive sequencing with clinical validation and genetic counselling.
Rayto Life and Analytical Sciences Co., Ltd. · China
Multi-analyte immunoassay for cancer screening and monitoring biomarkers. Supports oncology patient management and follow-up.
Guangzhou LBP Medicine Science & Technology Co.,Ltd. · China
Comprehensive tumor profiling panel utilizing LBP, IHC, PCR, and FISH methods to characterize tumor biology. This integrated approach provides multi-level diagnostic information for precision oncology.
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd · China
Comprehensive multigene panel for hereditary disease identification and cancer risk assessment. Provides clinical-grade analysis with detailed genomic reporting.
Daan Gene Co., Ltd. · China
Comprehensive PCR-based screening panel for multiple genetic diseases. Allows simultaneous detection of multiple genetic markers in single analysis.
YouSeq · United Kingdom
An NGS-based panel for detection of inherited genetic mutations associated with hereditary cancer syndromes. Enables identification of cancer predisposition for risk stratification and preventive clinical decision-making.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Comprehensive diagnostic panel for personalized treatment selection in cardiovascular and oncology diseases. Analyzes multiple genetic and molecular markers to guide clinical decision-making.
Genes 2Me Private Ltd · India
Precision NGS panel containing 774 genes designed for oncology and clinical genomics applications. Enables comprehensive genetic profiling for accurate detection of clinically relevant variants in cancer diagnostics.
87 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products